Related Experiment Video
Updated: Sep 5, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments
Leila Bahmani1,2, Mujib Ullah1,2
1Institute for Immunity and Transplantation, Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Palo Alto, CA 94304, USA.
Extracellular vesicles (EVs) are natural nanostructures showing therapeutic potential. This review highlights their benefits over cell therapies and synthetic platforms, discussing applications and challenges for clinical use.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Regenerative Medicine
Background:
- Extracellular vesicles (EVs) are cell-derived nanostructures with significant therapeutic potential.
- Their ability to bypass biological barriers and deliver cargo makes them promising for drug delivery and cell therapy alternatives.
- EVs are released from various cell types, mediating intercellular communication and altering target cell functions.
Purpose of the Study:
- To provide an overview of EV biophysical properties and their therapeutic advantages.
- To detail EVs from different cell sources, comparing their pros and cons.
- To summarize therapeutic effects of EVs in human disorders and discuss clinical translation challenges.
Main Methods:
- Literature review of preclinical studies on EV therapeutic efficacy.
- Analysis of EV biophysical properties and cargo delivery mechanisms.
- Comparative assessment of EVs from various cell origins.
Main Results:
- EVs offer intrinsic therapeutic benefits over traditional cell therapies and synthetic delivery systems.
- Diverse EV types from distinct cell sources exhibit varying therapeutic effects across multiple human disorders.
- Significant progress has been made in harnessing EVs for clinical applications.
Conclusions:
- EVs represent a competitive alternative to current cell therapies and drug delivery platforms.
- Further research is needed to address knowledge gaps and overcome hurdles for clinical translation of EV therapies.
- The review emphasizes the futuristic potential of EVs in medicine.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Clinical Applications of Epidermal Stem Cells
Microorganisms in Medicine and Therapeutics

